- LJP 394 - 90 - 14, A Randomized, Double-Blind, Placebo Controlled, Three-Arm, Parallel-Group, Multicenter, Multinational Safety and Efficacy Trial of 300 mg and 900 mg of Abetimus Sodium in Systemic Lupus Erythematosus (SLE) Patients with A History of Renal Disease.
- Principal Investigator: dr. Rachmat Gunadi W., SpPD-KR
- Sub Investigator: dr. Riardi Pramudiyo, SpPD-KR, dr. Sumartini Dewi, SpPD., M.Kes, dr. Laniyati Hamijoyo, SpPD-KR., M.Kes
- Status: Finished (Feasibility: 26 September 2007, Komite Etik: 4 Desember 2007, Site Initiation: 23 Januari 2008, Berakhir: 13 Perbruari 2009)
- Sponsor: La Jolla
- Jumlah Pasien: Screening 8, Randomisasi: 4
